These findings are consistent with other reports in which elevated caspase-8 levels were correlated with therapy resistance and impaired outcomes in hepatocellular carcinoma and triple-negative breast cancer [28,35]. The gene discussed is CASP8; the disease is triple-negative breast carcinoma.